These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26612646)

  • 1. Intracellular Platelet-Activating Factor Acetylhydrolase, Type II: A Unique Cellular Phospholipase A2 That Hydrolyzes Oxidatively Modified Phospholipids.
    Kono N; Arai H
    Enzymes; 2015; 38():43-54. PubMed ID: 26612646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating-factor acetylhydrolase II: A member of phospholipase A2 family that hydrolyzes oxidized phospholipids.
    Dong L; Li Y; Wu H
    Chem Phys Lipids; 2021 Sep; 239():105103. PubMed ID: 34116047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor acetylhydrolases: An overview and update.
    Kono N; Arai H
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):922-931. PubMed ID: 30055287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of PAF-Degrading Enzymes.
    Karasawa K; Inoue K
    Enzymes; 2015; 38():1-22. PubMed ID: 26612643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.
    Kono N; Inoue T; Yoshida Y; Sato H; Matsusue T; Itabe H; Niki E; Aoki J; Arai H
    J Biol Chem; 2008 Jan; 283(3):1628-1636. PubMed ID: 18024956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II.
    Matsuzawa A; Hattori K; Aoki J; Arai H; Inoue K
    J Biol Chem; 1997 Dec; 272(51):32315-20. PubMed ID: 9405438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.
    Liu J; Chen R; Marathe GK; Febbraio M; Zou W; McIntyre TM
    Circ Res; 2011 Feb; 108(4):469-77. PubMed ID: 21183738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of 45 kDa PAF acetylhydrolase from bovine colostrum.
    Moon TC; Son SY; Chang HW
    Biol Pharm Bull; 2007 Sep; 30(9):1668-73. PubMed ID: 17827718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.
    Min JH; Wilder C; Aoki J; Arai H; Inoue K; Paul L; Gelb MH
    Biochemistry; 2001 Apr; 40(15):4539-49. PubMed ID: 11294621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase.
    Castro Faria Neto HC; Stafforini DM; Prescott SM; Zimmerman GA
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():83-91. PubMed ID: 15962103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor acetylhydrolase (PAF-AH).
    Arai H; Koizumi H; Aoki J; Inoue K
    J Biochem; 2002 May; 131(5):635-40. PubMed ID: 11983068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of phospholipase activity of PAF acetylhydrolase.
    Stafforini DM; McIntyre TM
    Free Radic Biol Med; 2013 Jun; 59():100-7. PubMed ID: 22659315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of platelet-activating factor acetylhydrolase II in human skin.
    Marques M; Pei Y; Southall MD; Johnston JM; Arai H; Aoki J; Inoue T; Seltmann H; Zouboulis CC; Travers JB
    J Invest Dermatol; 2002 Oct; 119(4):913-9. PubMed ID: 12406338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor acetylhydrolase.
    Arai H
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():83-94. PubMed ID: 12432911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
    Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties.
    Stafforini DM; Rollins EN; Prescott SM; McIntyre TM
    J Biol Chem; 1993 Feb; 268(6):3857-65. PubMed ID: 8440681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of platelet-activating factor acetylhydrolase from peritoneal fluid obtained from guinea pigs after endotoxin shock.
    Karasawa K; Yato M; Setaka M; Nojima S
    J Biochem; 1994 Aug; 116(2):374-9. PubMed ID: 7822257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2).
    Stafforini DM
    Cardiovasc Drugs Ther; 2009 Feb; 23(1):73-83. PubMed ID: 18949548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II platelet-activating factor-acetylhydrolase is essential for epithelial morphogenesis in Caenorhabditis elegans.
    Inoue T; Sugimoto A; Suzuki Y; Yamamoto M; Tsujimoto M; Inoue K; Aoki J; Arai H
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13233-8. PubMed ID: 15340150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-bound plasma platelet activating factor acetylhydrolase acts on substrate in the aqueous phase.
    Min JH; Jain MK; Wilder C; Paul L; Apitz-Castro R; Aspleaf DC; Gelb MH
    Biochemistry; 1999 Sep; 38(39):12935-42. PubMed ID: 10504265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.